Fingerprint
Dive into the research topics of 'High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa
Mondana H. Ghias, Andrew D. Johnston, Allison J. Kutner, Robert G. Micheletti, H. Dean Hosgood, Steven R. Cohen
Research output: Contribution to journal › Article › peer-review
48
Scopus
citations